CJ Cheiljedang Corporation (097950.KS)
Seoul, KR
CJ Cheiljedang Corporation primarily operates within the food and biotechnology sectors. Its diverse range of food offerings encompasses prepared items like processed meats, frozen and fresh foods, along with culinary staples such as seasoning, sweeteners, flour, edible oils, and starch. The company also supplies specialty products including seaweed, desserts, snacks, and health-functional foods. In its biotechnology division, CJ Cheiljedang develops and provides amino acids and animal feed. Founded in 1953, the corporation's main offices are located in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.43% | -2.61% | -6.86% | +0.67% | -2.18% | +8.21% | -6.08% | -29.34% | -51.52% | -43.93% | -2.61% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 8 | -1 |
| Hold | 4 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%-6.9% Q1'26: -1.4% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%-485.7% Q1'26: +353.7% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+1.7% ★ Q1'26: +5.5% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+4.5% Q1'26: +3.3% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+3.4% Q1'26: +3.1% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+0.0% Q1'26: +49.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×4.18× Q1'26: 12.10× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 13 EPS Ana. |
Dec 2027 15 Rev. Ana. 14 EPS Ana. |
Dec 2028 6 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.92T
est: 13.00T (-0.6%)
|
14.56T
est: 14.48T (+0.6%)
|
16.48T
est: 16.42T (+0.4%)
|
18.67T
est: 18.43T (+1.3%)
|
22.35T
est: 22.32T (+0.1%)
|
24.25T
est: 24.43T (-0.7%)
|
26.29T
est: 25.84T (+1.7%)
|
30.08T
est: 30.30T (-0.7%)
|
29.02T
est: 29.27T (-0.8%)
|
29.36T
est: 29.35T (+0.0%)
|
27.34T
est: 29.17T (-6.3%)
|
28.58T
28.00T – 30.37T
-2.0% YoY
|
29.73T
28.39T – 32.30T
+4.1% YoY
|
31.20T
30.17T – 33.54T
+4.9% YoY
|
| EBITDA |
1.24T
est: 1.31T (-6.0%)
|
1.37T
est: 1.46T (-6.0%)
|
1.34T
est: 1.66T (-19.1%)
|
2.18T
est: 1.86T (+17.1%)
|
1.85T
est: 2.26T (-18.1%)
|
2.76T
est: 2.47T (+11.9%)
|
2.73T
est: 2.61T (+4.4%)
|
2.99T
est: 3.06T (-2.4%)
|
2.79T
est: 2.96T (-5.6%)
|
2.71T
est: 2.89T (-6.4%)
|
2.76T
est: 2.87T (-3.9%)
|
2.81T
2.76T – 2.99T
-2.0% YoY
|
2.93T
2.80T – 3.18T
+4.1% YoY
|
3.07T
2.97T – 3.30T
+4.9% YoY
|
| EBIT |
545.29B
est: 654.94B (-16.7%)
|
707.38B
est: 729.24B (-3.0%)
|
788.48B
est: 827.02B (-4.7%)
|
1.54T
est: 928.25B (+65.9%)
|
737.63B
est: 1.12T (-34.4%)
|
1.48T
est: 1.23T (+20.1%)
|
1.46T
est: 1.30T (+12.2%)
|
1.58T
est: 1.53T (+3.8%)
|
1.25T
est: 1.47T (-15.4%)
|
1.16T
est: 1.39T (-16.0%)
|
1.23T
est: 1.38T (-10.4%)
|
1.35T
1.32T – 1.43T
-2.0% YoY
|
1.40T
1.34T – 1.52T
+4.1% YoY
|
1.47T
1.42T – 1.58T
+4.9% YoY
|
| Net Income |
189.26B
est: 294.75B (-35.8%)
|
275.91B
est: 378.42B (-27.1%)
|
370.15B
est: 468.15B (-20.9%)
|
875.16B
est: 1.01T (-13.0%)
|
152.55B
est: 141.33B (+7.9%)
|
685.58B
est: 826.79B (-17.1%)
|
612.89B
est: 642.71B (-4.6%)
|
595.93B
est: 707.83B (-15.8%)
|
385.93B
est: 386.94B (-0.3%)
|
148.18B
est: 496.99B (-70.2%)
|
-571.46B
est: 363.59B (-257.2%)
|
385.03B
296.34B – 473.39B
+5.9% YoY
|
491.41B
348.15B – 628.94B
+27.6% YoY
|
561.70B
537.60B – 616.39B
+14.3% YoY
|
| SGA |
1.26T
est: 1.26T (-0.1%)
|
1.44T
est: 1.40T (+2.8%)
|
1.64T
est: 1.59T (+3.2%)
|
1.49T
est: 1.78T (-16.5%)
|
1.82T
est: 2.16T (-15.5%)
|
1.93T
est: 2.36T (-18.3%)
|
2.22T
est: 2.50T (-11.0%)
|
2.57T
est: 2.93T (-12.0%)
|
4.29T
est: 2.83T (+51.8%)
|
2.51T
est: 2.88T (-12.8%)
|
2.38T
est: 2.86T (-16.8%)
|
2.80T
2.75T – 2.98T
-2.0% YoY
|
2.92T
2.79T – 3.17T
+4.1% YoY
|
3.06T
2.96T – 3.29T
+4.9% YoY
|
| EPS |
13,401.00
est: 18,395.33 (-27.1%)
|
19,522.00
est: 23,617.33 (-17.3%)
|
26,179.00
est: 29,217.54 (-10.4%)
|
55,416.00
est: 62,809.11 (-11.8%)
|
9,520.34
est: 8,820.22 (+7.9%)
|
42,786.00
est: 51,600.03 (-17.1%)
|
38,246.00
est: 40,111.92 (-4.7%)
|
37,188.00
est: 44,176.09 (-15.8%)
|
24,081.00
est: 24,149.10 (-0.3%)
|
9,247.22
est: 31,007.43 (-70.2%)
|
-35,664.00
est: 22,684.37 (-257.2%)
|
24,022.19
18,489.14 – 29,535.01
+5.9% YoY
|
30,659.62
21,721.54 – 39,240.09
+27.6% YoY
|
35,045.05
33,541.54 – 38,457.12
+14.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Dividend Growth 211900.KS | 1.17% | 722.2K | 0.15% |
| 2 | Kodex Dividend Value 325020.KS | 0.26% | 224.1K | 0.30% |
| 3 | Kodex 200 Intrinsic Value 223190.KS | 0.24% | 45.1K | 0.30% |
| 4 | Kodex MSCI Value 275290.KS | 0.22% | 49.4K | 0.30% |
| 5 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.09% | 69.0K | 0.74% |
| 6 | Kodex 200ESG 337160.KS | 0.08% | 116.7K | 0.09% |
| 7 | Kodex KOSPI 226490.KS | 0.08% | 621.1K | 0.15% |
| 8 | Vanguard Global Value Equity Active ETF VVLU.AX | 0.08% | 710.0K | 0.28% |
| 9 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.08% | 93.8K | 0.42% |
| 10 | Kodex KOSPI100 237350.KS | 0.07% | 520.8K | 0.15% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ansan Jung | Head of Finance & Planning Department | — | male |
| Dimitrios Smyrnios | Executive Chairman of CJCJ Food - Americas | — | male |
| Eun-Ho Lee | Head of Investor Relations | — | — |
| Kyoung Suk Kang | Head of Finance Strategy Office | — | male |
| Sang Yeop Lim | Managing Director and Financial Team Manager | — | male |
| Sang-Min Kim | Head of Legal Team and Assistant Vice President | — | male |
| Seok-hwan Yoon | Chief Executive Officer | — | male |
| Stephan Czypionka | Global Chief Marketing Officer | — | male |
| Yong-Jun Sung | Assistant Vice President of Compliance | — | male |
| Young-Soo Shin | Managing Director and Head of HR Team | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 097950.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
